Gene · 4680
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytokine and epigenetic regulation of CEACAM6 mediates EGFR-driven signaling and drug response in lung adenocarcinoma. | NPJ Precis Oncol | 2025 | 40263546 | PubTator, text mining | PubMed |
| Diagnostic value of CEACAM6 and HE4 in pleural fluid for malignant pleural effusion. | Ann Med | 2025 | 40232301 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening Programmes. | Aliment Pharmacol Ther | 2025 | 40207404 | PubTator, text mining | PubMed |
| A Novel Theranostic Strategy for Malignant Pulmonary Nodules by Targeted CECAM6 with 89Zr/131I-Labeled Tinurilimab. | Adv Sci (Weinh) | 2025 | 40178153 | PubTator, text mining | PubMed |
| [CEACAM6 inhibits proliferation and migration of nasopharyngeal carcinoma cells by suppressing epithelial-mesenchymal transition]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | 40159971 | PubTator, text mining | PubMed |
| Comprehensive analysis of anoikis-related gene signature in ulcerative colitis using machine learning algorithms. | Front Med (Lausanne) | 2025 | 40115777 | PubTator, text mining | PubMed |
| Comprehensive Analysis of High-Sensitive Flow Cytometry and Molecular Mensurable Residual Disease in Philadelphia Chromosome-Positive Acute Leukemia. | Int J Mol Sci | 2025 | 40076750 | PubTator, text mining | PubMed |
| Integrative whole slide image and spatial transcriptomics analysis with QuST and QuPath. | NPJ Precis Oncol | 2025 | 40075141 | PubTator, text mining | PubMed |
| CircDIAPH1 Promotes Liver Metastasis and Development of Colorectal Cancer by Initiation of CEACAM6 Expression. | Mol Carcinog | 2025 | 39987565 | PubTator, text mining | PubMed |
| Flow cytometric characterisation of acute leukaemia in adolescent and adult Ethiopians. | Afr J Lab Med | 2025 | 39968161 | PubTator, text mining | PubMed |
| Identification of CD66c as a potential target in gastroesophageal junction cancer for antibody-drug conjugate development. | Gastric Cancer | 2025 | 39918687 | PubTator, text mining | PubMed |
| Successful cord blood transplantation for a unique case of bone marrow failure presenting t(2;19)(p23;q13.3) translocation suggesting disruption of DPY30. | Fukushima J Med Sci | 2025 | 39909446 | PubTator, text mining | PubMed |
| Development and biological evaluation of a novel CEACAM6-targeted PET tracer for distinguishing malignant nodules in early-stage lung adenocarcinoma. | Eur J Nucl Med Mol Imaging | 2025 | 39888423 | PubTator, text mining | PubMed |
| Broad-Spectrum Efficacy of CEACAM6-Targeted Antibody-Drug Conjugate with BET Protein Degrader in Colorectal, Lung, and Breast Cancer Mouse Models. | Mol Cancer Ther | 2025 | 39812376 | PubTator, text mining | PubMed |
| CEACAM6 facilitates gastric cancer progression through upregulating SLC27A2. | Cancer Gene Ther | 2025 | 39562695 | PubTator, text mining | PubMed |
| FunCoup 6: advancing functional association networks across species with directed links and improved user experience. | Nucleic Acids Res | 2025 | 39530220 | PubTator, text mining | PubMed |
| FLAER Revealed Normally Expected Non-PNH FLAER-Dim Immature Myeloid Cells (CD117+/CD34-) In Bone Marrow Aspirates and Could Be Utilized as a Marker of Hierarchical Hematopoiesis. | Int J Lab Hematol | 2025 | 39478200 | PubTator, text mining | PubMed |
| The influence of hypoxia-mediated CEACAM6 upregulation on epithelial cell and macrophage response in the context of gastric cancer. | Eur J Clin Invest | 2024 | 39674878 | PubTator, text mining | PubMed |
| Evolution of CEACAM pathogen decoy receptors in primates. | Eur J Clin Invest | 2024 | 39674876 | PubTator, text mining | PubMed |
| Elucidation of Dysregulated Pathways Associated With Hypoxia in Oestrogen Receptor-Negative Breast Cancer. | Cancer Med | 2024 | 39660488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4680/papers?page=6